Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QSP model building for nemolizumab response in atopic dermatitis
jRCT1050240261Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of nemolizumab in atopic dermatitis (AD) (2 cohorts), sponsored by Maruho Co., Ltd. Started Feb 2025; status: completed.
02
Drugs
nemolizumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1050240261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050240261.